This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: The University of Toledo. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Innovations by Francis Charles Brunicardi
Introduction
Francis Charles Brunicardi is a notable inventor based in Toledo, OH (US). He has made significant contributions to the field of cancer therapy through his innovative research and patented technologies. With a total of 2 patents, Brunicardi's work focuses on advanced methods for targeting cancer cells.
Latest Patents
Brunicardi's latest patents include "Targeting LASP1, EIF4A1, EIF4B and CXC4 with Modulators and Combinations Thereof for Cancer Therapy" and "Smart Exosomes for Active PDAC Targeting and Evading Mononuclear Phagocytotic System." The latter patent describes exosomes that express peptides in CD9 proteins, which are designed to deliver drugs, such as chemotherapeutic agents, directly to pancreatic cancer cells while evading the immune system's phagocytosis by macrophages. This innovative approach aims to enhance the efficacy of cancer treatments.
Career Highlights
Brunicardi is affiliated with the University of Toledo, where he conducts his research and development. His work has garnered attention for its potential to revolutionize cancer therapy and improve patient outcomes.
Collaborations
Some of his notable coworkers include Shi-He Liu and Dayanidhi Raman, who contribute to the collaborative efforts in advancing cancer research and therapy.
Conclusion
Francis Charles Brunicardi's innovative work in cancer therapy exemplifies the impact of targeted drug delivery systems. His patents reflect a commitment to improving treatment options for patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile